Add BrightSurf on Google Email

UTHealth Houston researchers awarded $2.6 million NIH grant to study molecular pathways and potential strategies for treatment of myocardial ischemia and reperfusion injury

Researchers at UTHealth Houston are studying the impact of circadian rhythm on heart attacks and cardiac surgery, with a focus on identifying novel therapies to protect the heart. They will investigate the role of key genes and signaling pathways in modulating daytime variations in cardiac injury.

Older adults from distressed communities attend less cardiac rehab after heart procedures

A Michigan Medicine-led study reveals that older adults from distressed communities are less likely to attend cardiac rehabilitation after coronary revascularization. The study found that only 26% of patients from these areas used cardiac rehab, compared to 46% from prosperous areas.

SourceMichigan Medicine - University of Michigan·JournalCirculation Cardiovascular Quality and Outcomes·TypeData/statistical analysis·DateOct 24, 2023

Stress levels worse in women who have heart attacks with blockages, study finds

A new study published in the Journal of the American College of Cardiology found that stress and depression are common among women at the time of heart attack and for two months after. However, researchers discovered that women with heart attacks due to blockages had higher stress levels than those with open arteries.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateOct 16, 2023

Cannabis use disorder may be linked to increased risk of cardiovascular disease

A new study has found a significant association between cannabis use disorder and an increased risk of cardiovascular disease events such as heart attacks and strokes. Adults with cannabis use disorder in Canada experienced a 60% higher risk of first-time cardiovascular disease events compared to those without the disorder.

SourceSociety for the Study of Addiction·JournalAddiction·TypeObservational study·DateSep 28, 2023

Patients who quit smoking after percutaneous coronary intervention do as well as non-smokers – unless they had smoked heavily

A large study of 74,471 patients found that those who quit smoking after percutaneous coronary intervention (PCI) have comparable rates of heart attacks, strokes, and deaths to non-smokers. However, heavy smokers showed no improvement in cardiovascular outcomes.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·TypeObservational study·DateSep 26, 2023

Treating high risk heart patients with immediate double cholesterol-lowering therapy could save thousands of lives each year

Research published in the Journal of the American Heart Association found that patients who start taking a combination of statins and ezetimibe after a heart attack are 47% less likely to die within three years. The study suggests that changing treatment guidelines could prevent many thousands of deaths each year.

SourcePolskie Towarzystwo Lipidologiczne (Polish Lipid Association)·JournalJournal of the American Heart Association·TypeObservational study·DateSep 6, 2023

Genetic study shows that common medication used to prevent heart attacks may be ineffective for majority of British South Asians

A genetic study of 44,396 British people of Bangladeshi and Pakistani ancestry found that 57% have a genetic variant that renders clopidogrel ineffective in preventing recurrent heart attacks. People with two loss of function variants were more than three times more likely to experience recurrent heart attacks due to treatment failure.

SourceQueen Mary University of London·JournalJournal of the American College of Cardiology·TypeData/statistical analysis·DateAug 21, 2023

CHEST releases clinical practice guideline on antithrombotic therapy in arterial thrombosis and thromboembolism in COVID-19

The American College of Chest Physicians (CHEST) has released a new clinical guideline for managing antithrombotic therapy in patients with COVID-19-related arterial thrombosis and thromboembolism. The guideline provides evidence-based recommendations to improve risk-evaluation and treatment course.

SourceAmerican College of Chest Physicians·Journalthe journal CHEST·TypeLiterature review·DateJun 29, 2023

Atherosclerosis accelerates aging

A new study by CNIC researchers reveals that low-grade systemic inflammation triggered by subclinical atherosclerosis accelerates epigenetic aging in otherwise healthy young individuals. The study found a strong association between atherosclerosis progression and accelerated biological age, with potential reversibility through lifestyl...

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalEuropean Heart Journal·TypeCase study·DateJun 21, 2023

Experimental cancer drug may slow inflammation linked to heart disease

A new study shows that saracatinib reduces inflammation in patients with atherosclerotic cardiovascular disease by more than 90% and boosts genes that help clean up plaque deposits. The experimental cancer drug may offer an effective therapy for cases where standard treatment fails to help.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalNature Cardiovascular Research·TypeExperimental study·DateJun 8, 2023

Obesity will become the most important risk factor for heart attacks within three decades

A study from the National University of Singapore predicts that obesity will be the main metabolic risk factor underlying acute myocardial infarction (AMI) onset and AMI-related deaths by 2050. By then, overweight/obesity related AMI-mortality is expected to increase four-fold, with Malays facing a five-fold rise.

Association between heart attack and cognition

A recent study of 30,465 adults without a history of heart attack or dementia found that those who experienced an MI had a faster rate of decline in global cognition, memory, and executive function compared to those without an MI. The study suggests that preventing heart attacks may be crucial for maintaining long-term brain health.

SourceJAMA Network·JournalJAMA Neurology·DateMay 30, 2023

Coronary bioresorbable scaffolds nearly as safe and effective as conventional metal stents for heart disease patients

A global clinical trial found that bioresorbable vascular scaffolds (BVS) are nearly as safe and effective as conventional metal stents in treating coronary artery disease. The study, led by a researcher from the Mount Sinai Hospital, showed improved outcomes for patients when properly implanted.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJournal of the American College of Cardiology·TypeRandomized controlled/clinical trial·DateMay 17, 2023

Diabetes drugs associated with fewer adverse cardiac events in older veterans

A retrospective cohort study of U.S. veterans found that adding a GLP1 receptor agonist to diabetes treatment reduced the risk of major adverse cardiovascular events and heart failure hospitalization by about 20% compared to DPP4 inhibitors. The study's findings will aid clinicians in choosing a diabetes drug regimen for older patients.

SourceVanderbilt University Medical Center·JournalAnnals of Internal Medicine·TypeObservational study·DateMay 8, 2023

The Texas Heart Institute and The University of Texas at Austin awarded a National Institutes of Health grant to develop injectable hydrogel electrodes to prevent ventricular arrhythmias

The Texas Heart Institute and The University of Texas at Austin receive a four-year, $2.37 million NIH grant to develop injectable hydrogel electrodes for preventing and managing ventricular arrhythmias. Researchers have already demonstrated the feasibility of pacing the heart using the hydrogel in a porcine model.

New Family Heart Foundation study reveals systemic underdiagnosis and undertreatment of homozygous familial hypercholesterolemia

A new study reveals delayed diagnosis of HoFH leads to premature cardiovascular disease, highlighting the need for increased lipid screening and aggressive treatment. Despite available therapies, most patients require further lipid-lowering treatments.

SourceFamily Heart Foundation·JournalJournal of the American Heart Association·TypeObservational study·DateMay 2, 2023